← Back to headlines
Cogent Biosciences Prepares for Bezuclastinib Launch Awaiting FDA Approval
Cogent Biosciences Inc. is gearing up for the launch of its drug Bezuclastinib, pending final approval from the FDA.
2 Mar, 07:57 — 2 Mar, 07:57
Sources
Showing 1 of 1 sources
Related Stories
Dutch Health Agency Warns of Potentially Fatal Trump-Shaped Ecstasy Pills
41m ago
48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room
2h ago
Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy
3h ago
Study Reveals Hidden Arterial Calcification in Young Adults
4h ago